|
Delayed
Nasdaq Stockholm
13:07:17 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.430 SEK | +0.24% |
|
-4.10% | -37.56% |
| 09-24 | Vivesto to present Paccal Vet data at conference | FW |
| 09-24 | Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.33M | - | - | - | - | - |
| 1,031B | |||||
| 638B | - | ||||
| 462B | |||||
| 359B | |||||
| 335B |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
